Phibro Animal Health Corp (PAHC)
23.72
-0.04
(-0.15%)
USD |
NASDAQ |
Nov 22, 16:00
23.72
0.00 (0.00%)
After-Hours: 16:46
Phibro Animal Health Net Income (Quarterly): 6.975M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.975M |
| June 30, 2024 | 0.752M |
| March 31, 2024 | 8.405M |
| December 31, 2023 | 1.274M |
| September 30, 2023 | -8.015M |
| June 30, 2023 | 11.50M |
| March 31, 2023 | 10.04M |
| December 31, 2022 | 7.21M |
| September 30, 2022 | 3.856M |
| June 30, 2022 | 7.487M |
| March 31, 2022 | 17.69M |
| December 31, 2021 | 17.46M |
| September 30, 2021 | 6.534M |
| June 30, 2021 | 17.12M |
| March 31, 2021 | 12.16M |
| December 31, 2020 | 12.80M |
| September 30, 2020 | 12.30M |
| June 30, 2020 | 5.642M |
| March 31, 2020 | 13.50M |
| December 31, 2019 | 11.89M |
| September 30, 2019 | 2.515M |
| June 30, 2019 | 8.802M |
| March 31, 2019 | 14.85M |
| December 31, 2018 | 14.75M |
| Date | Value |
|---|---|
| September 30, 2018 | 16.31M |
| June 30, 2018 | 22.12M |
| March 31, 2018 | 19.84M |
| December 31, 2017 | 7.032M |
| September 30, 2017 | 15.89M |
| June 30, 2017 | 15.38M |
| March 31, 2017 | 23.64M |
| December 31, 2016 | 13.42M |
| September 30, 2016 | 12.18M |
| June 30, 2016 | 15.22M |
| March 31, 2016 | 18.58M |
| December 31, 2015 | 30.18M |
| September 30, 2015 | 18.75M |
| June 30, 2015 | 10.40M |
| March 31, 2015 | 16.70M |
| December 31, 2014 | 14.25M |
| September 30, 2014 | 18.93M |
| June 30, 2014 | -17.64M |
| March 31, 2014 | 6.37M |
| December 31, 2013 | 2.302M |
| September 30, 2013 | 5.843M |
| June 30, 2013 | 5.979M |
| March 31, 2013 | 4.18M |
| December 31, 2012 | 12.07M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.015M
Minimum
Sep 2023
17.69M
Maximum
Mar 2022
8.830M
Average
9.224M
Median
Net Income (Quarterly) Benchmarks
| Boston Scientific Corp | 468.00M |
| Haemonetics Corp | 33.83M |
| Baxter International Inc | 140.00M |
| Globus Medical Inc | 51.84M |
| Insulet Corp | 77.50M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 260.43M |
| Total Expenses (Quarterly) | 242.73M |
| EPS Diluted (Quarterly) | 0.17 |
| Enterprise Value | 1.347B |
| Gross Profit Margin (Quarterly) | 32.06% |
| Profit Margin (Quarterly) | 2.68% |
| Earnings Yield | 1.81% |
| Operating Earnings Yield | 7.46% |
| Normalized Earnings Yield | 3.221 |